Heterocyclic oxime compounds

Details for Australian Patent Application No. 2010284972 (hide)

Owner Novartis AG

Inventors Dai, Miao; Fu, Xingnian; He, Feng; Jiang, Lei; Li, Yue; Liang, Fang; Liu, Lei; Mi, Yuan; Xu, Yao-Chang; Xun, Guoliang; Yan, Xiaoxia; Yu, Zhengtian; Zhang, Ji Yue

Agent Davies Collison Cave

Pub. Number AU-A-2010284972

PCT Pub. Number WO2011/020861

Priority PCT/ CN2010/071978 21.04.10 CN; 61/235,440 20.08.09 US; PCT/ CN2010/074089 18.06.10 CN

Filing date 18 August 2010

Wipo publication date 24 February 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/52 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 March 2012 PCT application entered the National Phase

  PCT publication WO2011/020861 Priority application(s): WO2011/020861

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010284977-Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders

2010284963-Variants of glucoamylase